Language: BG BG
← Back to results
Recruiting Not applicable NCT02995603

Patient Experience and Acceptance of Horizontal Rotation

No applicable phase (e.g. observational)
Conditions: Cancer

Sponsor: University of Sydney

trial.available_in: БГ
Overview
Patients will complete validated psychometric questionnaires to quantify their experience of being rotated at different speeds using the Nano-X patient rotation system.
Description
Study participants will be asked to attend the clinic on two separate occasions. Each session will last less than one hour. Patients will be asked to complete validated psychometric surveys assessing 1) their level of claustrophobia, 2) their level of anxiety and 3) their (baseline) motion sickness, before and after each session. They will then be rotated 3-4 times on the Nano-X patient rotation system, at varying speeds ranging from 6°/sec to 45°/sec. Each rotation will be designed to simulate a typical radiotherapy treatment; that is 9 angles, pausing for around 30 seconds at each angle. Straight after each rotation, patients will again complete the questionnaire assessing their anxiety levels and motion sickness.
Who can participate
Inclusion Criteria: 1. A diagnosis of cancer, any stage 2. ≥18 years of age 3. Eastern Cooperative Oncology Group (ECOG) status 0-2 4. Currently or previously being treated with radiotherapy 5. Any prior therapy allowed 6. Willing and able to comply with all study requirements 7. Must be able to read and complete questionnaires in English 8. Signed, written informed consent Exclusion Criteria: 1. Pregnant women 2. Mentally impaired patients or patients for whom attaining informed consent would be difficult (including language barriers) 3. Severe vertigo or recent diagnosis of Benign Paroxysmal Positioning Vertigo
Locations 1
Australia (1)
Prince of Wales Hospital
Randwick , New South Wales
Technical details
Status
Recruiting
Phase
Not applicable
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
14.12.2019
Completion date
01.06.2025
Registry ID
NCT02995603
Source
anzctr
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.